DDX5 and hepatocellular carcinoma: DDX5 is a negative regulator of the Wnt/β-catenin signaling pathway in HBV-associated HCC and is lowly expressed in HBV-associated HCC. miR17-92/miR106b-25 restored the expression level of DDX5 in HBV-associated HCC